Rat models to investigate host macrophage defense against trypanosoma cruzi

Journal of Innate Immunity

Volumn 3, Issue 1, 2011, Pages 71-82

  Fabrino, Daniela L ^a,b   Leon, Leonor Laura ^b   Genestra, Marcelo ^b   Parreira, Gleydes G ^c   Melo, Rossana C N ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chagas' disease; Heart; Immunopathology; Inflammation; Innate immunity; Monocytes macrophages; Parasitism; Rats; Trypanosoma cruzi

Indexed keywords

ARGINASE; NITRIC OXIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; ENZYME SYNTHESIS; HEART; HEART MUSCLE; HOST RESISTANCE; INFECTION CONTROL; INFECTION PREVENTION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE FUNCTION; MONOCYTE; NONHUMAN; PARASITEMIA; PARASITISM; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; TRYPANOSOMA CRUZI; WISTAR RAT;

ANIMALS; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; FEMALE; HEART; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGES; MONOCYTES; MYOCARDIUM; NITRIC OXIDE; PARASITEMIA; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TRYPANOSOMA CRUZI;

EID: 78650515159     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000320641     Document Type: Article

References (41)

1. Barrett MP, Burchmore RJ, Stich A, Lazzari JO, Frasch AC, Cazzulo JJ, Krishna S: The trypanosomiases. Lancet 2003;362:1469-1480.
2. Chagas C: New human trypanosomiasis. Morphology and lyfe cycle of Schysotrypanum cruzi, the course of a new human disease. Mem Inst Oswaldo Cruz 1909;1:159-218.
3. Tarleton RL, Reithinger R, Urbina JA, Kitron U, Gurtler RE: The challenges of Chagas disease - grim outlook or glimmer of hope. PLoS Med 2007;4: e332.
4. Teixeira AR, Nitz N, Guimaro MC, Gomes C, Santos-Buch CA: Chagas disease. Postgrad Med J 2006;82:788-798.
5. Melo RCN: Acute heart inflammation: ultrastructural and functional aspects of macrophages elicited by Trypanosoma cruzi infection. J Cell Mol Med 2009;13:279-294.
6. Fabrino DL, Leon LL, Parreira GG, Genestra M, Almeida PE, Melo RCN: Peripheral blood monocytes show morphological pattern of activation and decreased nitric oxide production during acute Chagas' disease in rats. Nitric Oxide 2004;11:166-174.
7. Denicola A, Rubbo H, Rodriguez D, Radi R: Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch Biochem Biophys 1993;304:279-286.
8. Rodrigues MM, Ribeirao M, Boscardin SB: CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism. Immunol Lett 2000;73:43-50.
9. Silva JS, Machado FS, Martins GA: The role of nitric oxide in the pathogenesis of Chagas disease. Front Biosci 2003;8: s314-s325.
10. Vespa GN, Cunha FQ, Silva JS: Nitric oxide is involved in control of Trypanosoma cruzi - induced parasitemia and directly kills the parasite in vitro. Infect Immun 1994;62:5177-5182.
11. Petray P, Castanos-Velez E, Grinstein S, Orn A, Rottenberg ME: Role of nitric oxide in resistance and histopathology during experimental infection with T rypanosoma cruzi. Immunol Lett 1995;47:121-126.
12. Brunet LR: Nitric oxide in parasitic infections. Int Immunopharmacol 2001;1:1457-1467.
13. De Oliveira L, Borges MM, Leal RC, Assreuy J, Kloetzel JK: Nitric oxide involvement in experimental Trypanosoma cruzi infection in Calomys callosus and Swiss mice. Parasitol Res 1997;83:762-770.
14. Saeftel M, Fleischer B, Hoerauf A: Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect Immun 2001;69:2252-2259.
15. Marinho CR, Nunez-Apaza LN, Martins-Santos R, Bastos KR, Bombeiro AL, Bucci DZ, Sardinha LR, Lima MR, Alvarez JM: IFN-γ, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Scand J Immunol 2007;66:297-308.
16. Cummings KL, Tarleton RL: Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infect Immun 2004;72:4081-4089.
17. Silva LHP, Nussenzweig V: Sobre a cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin Biol 1953;20:191-208.
18. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126:131-138.
19. Corraliza IM, Campo ML, Soler G, Modolell M: Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 1994;174:231-235.
20. Melo RCN, Machado CR: Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats. Exp Parasitol 2001;97:15-23.
21. Hanson WL, Roberson EL: Density of parasites in various organs and the relation to numbers of trypomastigotes in the blood during acute infections of Trypanosoma cruzi in mice. J Protozool 1974;21:512-517.
22. Melo RCN, Machado CR: Depletion of radiosensitive leukocytes exacerbates the heart sympathetic denervation and parasitism in experimental Chagas' disease in rats. J Neuroimmunol 1998;84:151-157.
23. Melo RCN: Depletion of immune effector cells induces myocardial damage in the acute experimental Trypanosoma cruzi infection: ultrastructural study in rats. Tissue Cell 1999;31:281-290.
24. Melo RCN, Fabrino DL, D'Avila H, Teixeira HC, Ferreira AP: Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo. Cell Biol Int 2003;27:853-861.
25. Maldonado IR, Ferreira ML, Camargos ER, Chiari E, Machado CR: Skeletal muscle regeneration and Trypanosoma cruzi-induced myositis in rats. Histol Histopathol 2004;19:85-93.
26. Ropert C, Ferreira LR, Campos MA, Procopio DO, Travassos LR, Ferguson MA, Reis LF, Teixeira MM, Almeida IC, Gazzinelli RT: Macrophage signaling by glycosylphosphatidylinositolanchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes. Microbes Infect 2002;4:1015-1025.
27. Melo RCN, D'Avila H, Fabrino DL, Almeida PE, Bozza PT: Macrophage lipid body induction by Chagas disease in vivo: putative intracellular domains for eicosanoid formation during infection. Tissue Cell 2003;35:59-67.
28. Melo RCN, Fabrino DL, Dias FF, Parreira GG: Lipid bodies: structural markers of inflammatory macrophages in innate immunity. Inflamm Res 2006;55:342-348.
29. Vincendeau P, Gobert AP, Daulouede S, Moynet D, Mossalayi MD: Arginases in parasitic diseases. Trends Parasitol 2003;19:9-12.
30. Devera R, Fernandes O, Coura JR: Should Trypanosoma cruzi be called 'cruzi' complex? A review of the parasite diversity and the potential of selecting population after in vitro culturing and mice infection. Mem Inst Oswaldo Cruz 2003;98:1-12.
31. Canto-Cavalheiro MM, Leon LL: Animal Models of Trypanosoma cruzi infection for experimental chemotherapy; in Merle Z (ed): Handbook of Animal Models of Infection. Bern, Swiss Tropical Institute, 1999, pp 799-808.
32. Coura JR: Chagas disease: what is known and what is needed - a background article. Mem Inst Oswaldo Cruz 2007;102(suppl 1):113-122.
33. Andrade V, Barral-Netto M, Andrade SG: Patterns of resistance of inbred mice to Trypanosoma cruzi are determined by parasite strain. Braz J Med Biol Res 1985;18:499-506.
34. Goncalves da Costa SC, Calabrese KS, Zaverucha do Valle T, Lagrange PH: Trypanosoma cruzi: infection patterns in intact and athymic mice of susceptible and resistant genotypes. Histol Histopathol 2002;17:837-844.
35. Graefe SE, Streichert T, Budde BS, Nurnberg P, Steeg C, Muller-Myhsok B, Fleischer B: Genes from Chagas susceptibility loci that are differentially expressed in T. cruzi-resistant mice are candidates accounting for impaired immunity. PLoS ONE 2006;1: e57.
36. Hideko Tatakihara VL, Cecchini R, Borges CL, Malvezi AD, Graca-de Souza VK, Yamada-Ogatta SF, Rizzo LV, Pinge-Filho P: Effects of cyclooxygenase inhibitors on parasite burden, anemia and oxidative stress in murine Trypanosoma cruzi infection. FEMS Immunol Med Microbiol 2008;52:47-58.
37. Machado CRS, de Oliveira DA, Magalhaes MJ, Carvalho EM, Ramalho-Pinto FJ: Trypanosoma cruzi infection in rats induced early lesion of the heart noradrenergic nerve terminals by a complement-independent mechanism. J Neural Transm Gen Sect 1994;97:149-159.
38. Moncayo A, Ortiz Yanine MI: An update on Chagas disease (human American trypanosomiasis). Ann Trop Med Parasitol 2006;100:663-677.
39. DaMatta RA, Seabra SH, Manhaes L, de Souza W: Nitric oxide is not involved in the killing of Trypanosoma cruzi by chicken macrophages. Parasitol Res 2000;86:239-243.
40. Seabra SH, de Souza W, DaMatta RA: Toxoplasma gondii partially inhibits nitric oxide production of activated murine macrophages. Exp Parasitol 2002;100:62-70.
41. Olivares Fontt E, Heirman C, Thielemans K, Vray B: Granulocyte-macrophage colonystimulating factor: involvement in control of Trypanosoma cruzi infection in mice. Infect Immun 1996;64:3429-3434.